Nucleic Acid Labeling Market size is anticipated to surpass USD 4 Billion by the end of 2033, growing at a CAGR of 9% during the forecast period i.e., 2023-2033. In the year 2022, the industry size of nucleic acid labeling was over USD 1 Billion. The growth of the market can be attributed to the increasing use of polymerase chain reaction (PCR) tests and DNA sequencing across hospitals and laboratory centers owing to the outbreak of various infectious diseases such as the COVID-19 pandemic. For instance, in February 2021, more than 1 million PCR tests were performed in the United States as a consequence of the COVID-19 pandemic. The PCR test is used to determine the genetics of an organism to find out whether it is a virus, bacteria, or any other organism. It is used to find the type of disease or infection a patient is suffering from, so that appropriate treatment is indicated to the patient. The prevalence of infectious diseases across the world that are both contagious and asymptomatic is estimated to drive market growth.
Moreover, the development of healthcare facilities, increasing awareness of early disease diagnosis, along with increasing per capita income are anticipated to propel the demand for nucleic acid labeling during the forecast period. The World Bank reported a 4.8% increase in worldwide income per capita in 2021, compared with 1.5% in 2019. People are becoming more aware of their health with the adoption of early diagnosis tests. The spread of COVID-19 made people more conscious of getting tested if they saw any symptoms that were not common. The government is also paying much attention to the healthcare sector, as it is crucial for a healthy community. Also, the spread of genetic disorders is something that cannot be changed after their incidence. Therefore, it is better to prevent the cause through genetic material testing. Thus, the growth of the market is expected to grow during the forecast period.
Growth Drivers
Challenges
|
Base Year |
2022 |
|
Forecast Year |
2023-2033 |
|
CAGR |
~9% |
|
Base Year Market Size (2022) |
~ USD 1 Billion |
|
Forecast Year Market Size (2033) |
~ USD 4 Billion |
|
Regional Scope |
|
Product Type (Reagents, Kits)
The global nucleic acid labeling market is segmented and analyzed for demand and supply by product type into reagents, and kits. Among these segments, the kits segment is anticipated to capture the largest market size in the global nucleic acid labeling market. The growing application of DNA labeling and detection products for detection and purification is expected to drive segment growth during the forecast period. Moreover, the surge in cases of COVID-19 along with the development of advanced labeling kits by key manufacturers for COVID- 19 diagnostics, is further anticipated to fuel segment growth. For instance, Perkin Elmer Inc's new COVID-19 nucleic acid detection kit is an in vitro real-time RT-PCR diagnostic kit for detecting nucleic acid from SARS-CoV-2 in humans with 48 tests included in the kit. The kits help to avoid long waiting times in lines at hospitals and the risk of infections is more in health facilities. The home-tested kits also help to prevent traveling chargers. Even health professionals will save time as everything is assembled in the kit which is disposable after use.
Application (DNA sequencing, PCR, FISH,Microarray, In Situ Hybridization, Blotting)
The global nucleic acid labeling market is also segmented and analyzed for demand and supply by application into DNA sequencing, PCR, FISH, microarray, In situ hybridization, botting, and others. The In-situ hybridization segment is estimated to garner the largest share. The rising prevalence of genetic disorders and increasing use of In-situ hybridization in the manufacturing of cancer and genetic disorder drugs or medicines. The increasing growth of infections among people as well as research and development funds to improve the market segment growth is estimated to drive the growth of the market. It is also used to understand the disease such as the DNA or chromosomal abnormalities that cause the disorder. Rising pharmaceutical, diagnostic, and biopharmaceutical companies boost the growth of the segment. As per the estimations of the World Health Organization, about 10 in 1000 people are affected by the monogenic disease across the world.
Our in-depth analysis of the global market includes the following segments:
|
By Product Type |
|
|
By Labeling Technique |
|
|
By Application |
|
|
By End User |
|
The North American nucleic acid labeling market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2033. The growth of the market can be attributed majorly to the growing genomics research, attractive reimbursement policies, and convenient access to new diagnostic solutions owing to the presence of key emerging companies in the region. Furthermore, the increasing spending on healthcare and Medicare along with increased R&D expenditures are expected to drive the nucleic acid labeling market growth in the region during the forecast period. According to the Centers for Medicare & Medicaid Services, a total of USD 4.1 trillion was spent on health care in the United States in 2020, representing an increase of 9.7 percent. Also, in 2020, Medicare expenditures increased by 3.5% to USD 829.5 billion. The study of the genetic material of an organism is helpful in determining the protein structure and building mechanism. Therefore, it is an active ingredient or drug is developed to prevent its growth in or on the human body. DNA is the key to many medicinal discoveries that help to treat diseases that are chronic and harmful.
ThermoFisher Scientific Inc., announced the launch of the Thermo Scientific SpeciMAX Stabilized Saliva Collection Kit. To ensure sample safety, this kit inactivates common respiratory viruses to preserve viral nucleic acids.
New England Biolabs (NEB) released Monarch Genomic DNA Purification Kit, by expanding its Monarch Nucleic Acid Purification portfolio. This kit provides extremely high yields of DNA fragment purification and prevents contamination of RNA.
Author Credits: Radhika Gupta, Shivam Bhutani
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?